The year 2025 is already delivering promising results in oncology research, with new data highlighting long-term treatment durability, innovative lung cancer therapies, and advances in minimal residual disease (MRD) detection. Updates reported by Clinical Trial Vanguard illustrate how sustained efficacy, precision targeting, and biomarker-driven strategies are reshaping cancer care for patients worldwide. One of the […]